Top 5 Stocks for July

Top Stock 1 – AutoZone (AZO[2])

AutoZone (AZO[2]) is a recession-proof stock, since the company is capitalizing
on the fact that Americans are buying fewer new cars and maintaining their old vehicles longer.

As major car companies deal with bankruptcy, this trend will only continue. In its latest quarter, the company’s earnings rose
22%, and sales jumped 8%. Growing year-over-year earnings in this dismal environment is a tremendous feat.

The best part is that this company is poised to pick up a huge chunk of market share as Chrysler and General Motors head down
the drain. Since the dealer networks and parts businesses of these companies will likely suffer during the process, AZO will quickly
fill the void.

NEXT: Top Stock #2 – Apollo Group (APOL)

Top Stock 2 – Apollo (APOL[3])

Apollo Group (APOL[3]) is a point of great debate, but I am sticking to my guns
on this one. I take literally a dozen of questions every week about this stock’s gyrations, but my answer is always a resounding “buy” for
APOL.

You see, Apollo Group is one of those famous “zig zag” stocks that tends to do well on down market days and moves very differently
from the overall stock market. This is because Apollo’s University of Phoenix is the #1 private education provider in the nation
and has seen booming enrollment as more Americans are laid off.

So as jobless claims make Wall Street grumpy, they also boost this stock. And that’s the primary reason that I am recommending
Apollo Group – because it helps to stabilize your portfolio on down days.

On top of that, the long-term unemployment picture is very grim. Overall unemployment rose by 787,000 in May to 14.5 million,
so the unemployment rate rose from 8.9% to 9.4% to the highest rate in 26 years! Since many displaced workers will likely continue
go back to school for retraining, I am confident this trend will pay off for Apollo.

NEXT: Top Stock #3 – Amgen (AMGN)

Top Stock 3 – Amgen (AMGN[4])

Amgen (AMGN[4]) is in the recession-proof health care sector and has seen strong
sales and earnings even during the recent turmoil on Wall Street.

Amgen is the largest biotechnology company in the world and has products to fight cancer, kidney disease and arthritis. Amgen
currently has five “blockbuster” drugs on the market that generate more than $1 billion in annual sales.

This stock consolidated briefly after reporting a slip in sales at the end of April, but the stock has come roaring back nearly
15% since then.

I expect another big leg up for Amgen in anticipation of 2Q earnings, so get into this company right now.

Get Louis Navellier’s latest updates and Buy Below prices on his Top 5 Stocks for July by accepting a six-month, risk-free
trial to Blue Chip Growth. Click here for details on how to join for just $99[5].

NEXT: Top Stock #4 – Quest Diagnostics (DGX)

Top Stock 4 – Quest Diagnostics (DGX[6])

An aging population and a greater emphasis on preventative care are creating a high-growth opportunity for Quest Diagnostics (DGX[6]).
This company is the leading provider of independent diagnostic testing in the U.S. It has built a network of more than 2,000 patient
service centers across the country, offering its customers a wide array of routine and specialty laboratory tests and services.

DGX posted a nearly 25% jump in earnings for the first quarter and a significant uptick in sales that beat expectations. These
are very solid results in an economic environment where most of Quest’s primary customers have decided to perform more diagnostic
testing in-house to cut spending.

Quest is poised for another round of great earnings, and now is the time to jump into this stock during the lull before the
next quarterly reporting season.

NEXT: Top Stock #5 – McDonald’s (MCD)

Top Stock 5 – McDonald’s (MCD[7])

McDonald’s (MCD[7]) has been one of my favorite stocks to talk about lately, since
it is the “poster stock” for how a weaker dollar boosts corporate profits in multinational companies with a global footprint.

Just recently, the company reported a tremendous 5% increase in international same-store sales for May, fueled largely by favorable
currency exchange rates. As the dollar continues to weaken, we will see even bigger numbers from MCD.

The success of McDonald’s McCafe business will help to sustain same-store sales growth until the dollar’s weakness shifts exchange
rates to the company’s favor. MCD also has a high dividend yield, which makes it an attractive investment to investors.

Get Louis Navellier’s latest updates and Buy Below prices on his Top 5 Stocks for July by accepting a six-month, risk-free
trial to Blue Chip Growth. Click here for details on how to join for just $99[5].

NEXT: How Do the Stocks in Your Portfolio Measure Up?